As a biologically active ingredient, it can inhibit the expression of the proto-oncogene c-Myc by affecting the MAPK/ERK pathway initiated by EGF/EGFR, thereby inhibiting the proliferation of gastric cancer cells. Here, EGFR is linked to gastric cancer.